Company: PHAT
Filing Date: 2025-05-01
Form Type: 8-K
Source: 0001193125-25-108726
Chunk: 1

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-05-01
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01.      Financial Statements and Exhibits.  

(d) Exhibits

  Exhibit      Description                                                                  
                                                                                            
      No.                                                                                   
     99.1      Press Release issued on May 1, 2025                                          
 ────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                         PHATHOM PHARMACEUTICALS, INC.                                            
  Date: May 1, 2025      By:                                /s/ Steven Basta                      
                                                            Steven Basta                          
                                                            Chief Executive Officer and Director